An asymmetric synthesis of (+)-isonitramine by 'triple allylic strain-controlled' intramolecular S(N)2' alkylation

DOI: 10.1016/0040-4039(96)00023-8

Source and publish data:

Tetrahedron Letters p. 1433 - 1434 (1996)

Update date:2022-08-05

Topics:

Authors:

Kim Kim

Choi Choi

Hong Hong

Park Park

Kim Kim

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0040-4039(96)00023-8

The spirocyclic alkaloid (+)-isonitramine (1) has been synthesized in a stereoselective manner utilizing a novel 'triple allylic strain-controlled' intramolecular lactam enolate S(N)2' alkylation.

Full text of DOI:10.1016/0040-4039(96)00023-8

Products guided by the article

Product name:(+)-isonitramine

Cas No:65620-67-9

R&D Labs maybe for 65620-67-9

Angelisun(Chongqing) Pharmaceutical Co., LTD.

Contact:+86-23-68030926-816

Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Chengdu Yunyi International Trade Co., Ltd

Contact:

Address:china
HANGZHOU YUNUO CHEMICAL CO.,LTD

website:http://www.yunuochem.com

Contact:0571-83715115

Address:hangzhou
Beijing Pure Chem Co.,Ltd.

Contact:+86-10-83993285

Address:Rm.1708, Haobai Tower, Building 6, No.50, North Road, West Third Ring, Haidian District, Beijing, China
Shantou Baokang Pharmaceutical Co., Ltd.

Contact:+86-754-88873487

Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou

Relevant to this article

An unexpected synthesis of novel oxygen-bridged 1,5-benzothiazepine derivatives and their reductive five-membered-ring opening

Doi:10.1007/s007060050320
(2000)
Reaction of methylpyrimidine derivatives with isoamyl nitrite

Doi:10.1248/yakushi1947.90.7_877
(1970)
Doi:10.1039/j39700001469
(1970)
Synthesis of a D,D- and L,D-heptose-containing hexasaccharide corresponding to a structure from Haemophilus ducreyi lipopolysaccharides

Doi:10.1016/S0957-4166(99)00554-6
(2000)
Radical cyclisation studies of β-nitroamines from the nitro-Mannich reaction

Doi:10.1016/j.tet.2018.06.022
(2018)
Potent, orally absorbed glucagon receptor antagonists

Doi:10.1016/S0960-894X(99)00081-5
(1999)

Article Doi